Complete response to chemotherapy in a 6-year survivor of metastatic pancreatic cancer

Keyphrases

• Survivors 100%
• Chemotherapy 100%
• Complete Response 100%
• Response to Chemotherapy 100%
• Metastatic Pancreatic Cancer 100%
• Tumor Marker 66%
• Metastatic Pancreatic Adenocarcinoma 66%
• Clinical Trials 33%
• Long-term Survivors 33%
• Surgical Options 33%
• Abdominal Pain 33%
• No Evidence of Disease 33%
• Chemotherapy Alone 33%
• Pancreatic Lesions 33%
• Gemcitabine 33%
• Liver Lesions 33%
• Jaundice 33%
• Complete Regression 33%
• Ibrutinib 33%
• Nab-paclitaxel 33%

Medicine and Dentistry

• Pancreas Cancer 100%
• Pancreas Adenocarcinoma 100%
• Tumor Marker 100%
• Clinical Trial 50%
• Adenocarcinoma 50%
• Liver Injury 50%
• Paclitaxel 50%
• Abdominal Pain 50%
• Gemcitabine 50%
• Jaundice 50%
• Diseases 50%
• Ibrutinib 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Pancreas Cancer 100%
• Pancreas Adenocarcinoma 40%
• Tumor Marker 40%
• Clinical Trial 20%
• Paclitaxel 20%
• Liver Injury 20%
• Gemcitabine 20%
• Adenocarcinoma 20%
• Abdominal Pain 20%
• Jaundice 20%
• Diseases 20%
• Ibrutinib 20%